ストックスクリーナーアプリを入手
72.90
0.25%
-0.18
アフターアワーズ：
72.36
-0.54
-0.74%
前日終値:
$73.08
開ける：
$73.03
24時間の取引高:
4.33M
Relative Volume:
0.86
時価総額：
$28.06B
収益：
$4.66B
当期純損益:
$836.30M
株価収益率:
34.83
EPS:
2.093
ネットキャッシュフロー:
$1.08B
1週間 パフォーマンス:
-0.36%
1か月 パフォーマンス:
+2.94%
6か月 パフォーマンス:
-9.73%
1年 パフォーマンス:
-11.55%
1日の値動き範囲:
$71.10
$73.57
1週間の範囲:
$71.10
$74.43
52週間の値動き範囲:
$54.11
$89.98
Dexcom Inc Stock (DXCM) Company Profile
Compare DXCM vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
72.90 | 28.13B | 4.66B | 836.30M | 1.08B | 2.093 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-12 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2025-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 開始されました | Evercore ISI | In-line |
| 2025-10-21 | 再開されました | Stifel | Buy |
| 2025-09-08 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 開始されました | Argus | Buy |
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-05-30 | 開始されました | Goldman | Buy |
| 2025-04-10 | 開始されました | Mizuho | Outperform |
| 2025-02-03 | アップグレード | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 開始されました | Redburn Atlantic | Neutral |
| 2024-03-12 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-04-17 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2023-01-26 | 開始されました | Wolfe Research | Outperform |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-15 | 開始されました | Bernstein | Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-03 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-01-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2021-10-18 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-28 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2021-01-06 | アップグレード | UBS | Neutral → Buy |
| 2020-10-02 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 繰り返されました | Piper Sandler | Overweight |
| 2020-05-14 | 開始されました | Wells Fargo | Equal Weight |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-11-07 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-11-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-10-23 | 開始されました | Stifel | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-10-19 | アップグレード | Goldman | Sell → Neutral |
| 2018-09-12 | アップグレード | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 繰り返されました | Canaccord Genuity | Buy |
| 2018-07-02 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 開始されました | BofA/Merrill | Buy |
| 2018-05-03 | 繰り返されました | Canaccord Genuity | Buy |
| 2018-04-04 | 開始されました | Goldman | Sell |
| 2018-04-04 | 開始されました | Guggenheim | Neutral |
| 2018-03-23 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | ダウングレード | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 繰り返されました | Wedbush | Outperform |
すべてを表示
Dexcom Inc (DXCM) 最新ニュース
DexCom: Gaining Favor, With Useful Tailwinds To Support It Even Further (NASDAQ:DXCM) - Seeking Alpha
Picton Mahoney Asset Management Acquires 26,106 Shares of DexCom, Inc. $DXCM - MarketBeat
CI Investments Inc. Increases Position in DexCom, Inc. $DXCM - MarketBeat
Elo Mutual Pension Insurance Co Has $3.66 Million Stock Position in DexCom, Inc. $DXCM - MarketBeat
How Adding Google’s Rick Osterloh To Dexcom’s Board (DXCM) Could Reframe Its Investment Story - simplywall.st
Nasdaq 100 Stock Outlook 2026: DexCom vs. Comcast & Warner Bros. DiscoveryNews and Statistics - IndexBox
Champlain Investment Partners LLC Decreases Stake in DexCom, Inc. $DXCM - MarketBeat
Intech Investment Management Reduces DexCom Stake - National Today
Rafferty Asset Management Boosts DexCom Holdings - National Today
Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U - Quantisnow
TD Asset Management Boosts DexCom Stake by 16% - National Today
DexCom, Inc. (DXCM) Stock Analysis: 16.91% Potential Upside Amid Robust Growth Metrics - DirectorsTalk Interviews
DexCom (DXCM) Announces Leadership Transition and Compensation D - GuruFocus
American Century Companies Inc. Reduces DexCom Stake - National Today
Dexcom Executive Chairman Kevin Sayer Returns From Leave - TipRanks
Kevin Sayer returns as Dexcom (NASDAQ: DXCM) executive chairman - Stock Titan
DexCom, Inc. $DXCM Shares Sold by American Century Companies Inc. - MarketBeat
TD Asset Management Inc Buys 44,770 Shares of DexCom, Inc. $DXCM - MarketBeat
Quantbot Technologies LP Buys 92,273 Shares of DexCom, Inc. $DXCM - MarketBeat
Rafferty Asset Management LLC Grows Holdings in DexCom, Inc. $DXCM - MarketBeat
Erste Asset Management GmbH Has $1.66 Million Holdings in DexCom, Inc. $DXCM - MarketBeat
Intech Investment Management LLC Sells 66,221 Shares of DexCom, Inc. $DXCM - MarketBeat
Allianz SE Sells 43,425 Shares of DexCom, Inc. $DXCM - MarketBeat
DXCM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Handelsbanken Fonder AB Grows Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Purchases 53,341 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom Inc. stock underperforms Friday when compared to competitors - MarketWatch
DexCom, Inc. Experiences Revision in Stock Evaluation Amid Market Fluctuations - Markets Mojo
DNB Asset Management AS Acquires 803,086 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Purchased by Banco Santander S.A. - MarketBeat
DexCom (DXCM) Expands Board with New Appointment - GuruFocus
Dexcom Adds Google Executive Rick Osterloh to Board - TipRanks
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Dexcom appoints Google executive Rick Osterloh to board - Investing.com
Dexcom (NASDAQ: DXCM) director awarded 7,061 restricted stock units - Stock Titan
[Form 3] DEXCOM INC Initial Statement of Beneficial Ownership - Stock Titan
Dexcom Appoints Rick Osterloh to Board of Directors - The Joplin Globe
Rick Osterloh of Google joins Dexcom (NASDAQ: DXCM) board effective Feb. 26 - Stock Titan
DexCom, Inc. Appoints Rick Osterloh to Board of Directors, Effective February 26, 2026 - marketscreener.com
Westfield Capital Management Co. LP Trims Stake in DexCom, Inc. $DXCM - MarketBeat
Aristotle Growth Equity Fund Bets on DexCom (DXCM) Due to Its Expanding CGM Market Leadership - Insider Monkey
Fox Run Management L.L.C. Purchases Shares of 18,368 DexCom, Inc. $DXCM - MarketBeat
HighTower Advisors LLC Lowers Stake in DexCom, Inc. $DXCM - MarketBeat
DexCom Weighs GLP 1 CGM Tailwind Against Valuation And Momentum Signals - Yahoo Finance
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT - GuruFocus
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Morningstar
Assessing DexCom (DXCM) Valuation After Short Term Gains And A 14.5% Undervaluation Narrative - simplywall.st
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars - The Globe and Mail
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars - The Motley Fool
Dexcom announces upcoming conference presentation - marketscreener.com
BTIG Research Reiterates Buy Rating for DexCom (NASDAQ:DXCM) - MarketBeat
Dexcom Inc (DXCM) 財務データ
収益
当期純利益
現金流量
EPS
1.94%
0.12%
大文字化:
|
ボリューム (24 時間):